In 2009, inactivated somatic mutations and deletions targeting the UTX gene were identified in a variety of human cancers including multiple myeloma, medulloblastoma, esophageal, colon, bladder, prostate, and renal cancer [8,9,10,11]. Here, KDM6A is linked to plasma cell myeloma.